Search results
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
WKRN Nashville· 7 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...
Swiss Market Ends On Strong Note
RTT News· 6 days agoSwiss stocks closed on a buoyant note on Friday, tracking gains in global markets amid optimism several central banks will start cutting interest rates soon..
Opinion | Ending Oncology's Toxic Relationship With High Chemotherapy Doses
MedPage Today· 6 days agoMany years ago, my patient, a woman in her fifties with chronic myeloid leukemia (CML), got her...
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 hours agoVenetoclax has shown activity against the [anti-up total] protein Bcl-2 and works by neutralizing the protein's BH-3 domain. It is an approved treatment for chronic lymphocytic ...
Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze
Market Watch· 16 hours agoAlthough as it still has no drugs approved by the Food and Drug Administration, incremental updates...
Benjamin F. Edwards & Company Inc. Buys Shares of 542 BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 3 days agoBenjamin F. Edwards & Company Inc. purchased a new stake in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 14 hours agoPRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures with
BNP Paribas Financial Markets Acquires 26,818 Shares of Incyte Co. (NASDAQ:INCY)
ETF DAILY NEWS· 1 day agoBNP Paribas Financial Markets boosted its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 9.7% during the fourth quarter, according to the company in its most recent filing with ...
Inspiration4 data access through the NASA Open Science Data Repository - npj Microgravity
Nature· 2 days agoThe increasing accessibility of commercial and private space travel necessitates a profound understanding of its impact on human health. The NASA Open Science Data Repository (OSDR) provides ...
Terns Pharmaceuticals Inc (TERN) Q1 2024 Earnings: Misses Analyst Net Loss Projections
GuruFocus.com via Yahoo Finance· 3 days agoKey updates include ongoing Phase 1 trials for TERN-701 and TERN-601, targeting chronic myeloid leukemia (CML) and obesity, respectively ...
